Table 3.

Transplantation of individually sorted Lineageint c-kit+ sca-1+ CD34 cells

 WT;GFP+ V617F;GFP+ 
 Exp. 1 n.a. n.a. 18/40 (45%) 2/40 (5.0%) 1/2 (50%) 
 Exp. 2 n.a. n.a. 5/58 (8.6%) 2/58 (3.4%) 1/2 (50%) 
 Total n.a. n.a. 23/98 (23.5%) 4/98 (4.1%) 2/4 (50%) 
Calculated frequencies     
 ST-HSC LT-HSC ST-HSC LT-HSC MPN initiating cells 
 n.a. n.a. 1 in 4.3 1 in 24.4 1 in 2 
 WT;GFP+ V617F;GFP+ 
 Exp. 1 n.a. n.a. 18/40 (45%) 2/40 (5.0%) 1/2 (50%) 
 Exp. 2 n.a. n.a. 5/58 (8.6%) 2/58 (3.4%) 1/2 (50%) 
 Total n.a. n.a. 23/98 (23.5%) 4/98 (4.1%) 2/4 (50%) 
Calculated frequencies     
 ST-HSC LT-HSC ST-HSC LT-HSC MPN initiating cells 
 n.a. n.a. 1 in 4.3 1 in 24.4 1 in 2 

Single sorted GFP-positive HSCs were injected into lethally irradiated recipients together with 200,000 GFP-negative WT BM cells. Reconstitution was scored based on the presence of >1% GFP-positive cells in the PB Gr1+ cells at ∼4 mo after transplantation. n.a., not applicable.

or Create an Account

Close Modal
Close Modal